A novel circular RNA (circRNA) therapeutic demonstrated profound efficacy in alleviating osteoarthritis progression in male mice through targeted protein replacement mechanisms. This approach represents a significant advancement beyond traditional gene therapies by utilizing circRNAs’ stability and translational capacity. Published in Nature Communications, the study highlights circRNA’s potential as a versatile platform for degenerative disease treatment strategies.